Search results
Merck & Co., Inc. (NYSE:MRK) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Simply Wall St. via Yahoo Finance· 1 day agoMerck & Co., Inc. (NYSE:MRK) just released its quarterly report and things are looking bullish. The...
Sigma Planning Corp Sells 25,974 Shares of Merck & Co., Inc. (NYSE:MRK)
ETF DAILY NEWS· 7 days agoSigma Planning Corp reduced its stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 56.2% during the ...
Q3 2024 Earnings Forecast for Merck & Co., Inc. Issued By Leerink Partnrs (NYSE:MRK)
ETF DAILY NEWS· 7 days agoMerck & Co., Inc. (NYSE:MRK – Free Report) – Research analysts at Leerink Partnrs raised their Q3 2024 earnings per ...
Merck stock gains on Q1 2024 beat (NYSE:MRK)
Seeking Alpha· 4 days agoMerck (MRK) stock gains as the company posts better than expected Q1 2024 financials with strong sales growth from its cancer medicine Keytruda. Read...
What Direction Does Merck & Co Inc (NYSE: MRK) Analysts Think The Company Will Take? – Stocks...
Stocks Register· 5 days agoThe trading price of Merck & Co Inc (NYSE:MRK) remained unchanged on Tuesday, April 23, closing at $126.88. The company ...
Here’s Why Merck & Co. (MRK) Outperformed in Q1
Insider Monkey via Yahoo Finance· 6 days agoBaron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be...
Merck stock target raised on strong Q1 results By Investing.com
Investing.com· 2 days agoOn Friday, Wells Fargo adjusted its outlook on shares of pharmaceutical giant Merck & Co., Inc....
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks via Yahoo Finance· 3 days agoZacks Rank & Stocks to Consider Merck currently has a Zacks Rank #3 (Hold). Merck & Co., Inc. Price...
We Think Merck (NYSE:MRK) Can Stay On Top Of Its Debt
Simply Wall St. via Yahoo Finance· 3 days agoSo it might be obvious that you need to consider debt, when you think about how risky any given...
Merck raises 2024 profit forecast on strong cancer, HPV drugs sales
Reuters· 4 days agoThe New Jersey-based drugmaker said it expected earnings of $8.53 and $8.65 per share, up from its...